Vyne Therapeutics Inc
NASDAQ:VYNE

Watchlist Manager
Vyne Therapeutics Inc Logo
Vyne Therapeutics Inc
NASDAQ:VYNE
Watchlist
Price: 0.5564 USD 0.51% Market Closed
Market Cap: 18.5m USD

Net Margin
Vyne Therapeutics Inc

-6 421%
Current
-6 557%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-6 421%
=
Net Income
-33.6m
/
Revenue
524k

Net Margin Across Competitors

No Stocks Found

Vyne Therapeutics Inc
Glance View

Market Cap
17.7m USD
Industry
Pharmaceuticals

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. The company is headquartered in Bridgewater, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-01-25. The firm is engaged in developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions and rare skin diseases with high unmet medical need. The Company’s proprietary pipeline FMX114, which is a potential treatment of mild-to-moderate atopic dermatitis in patients 12 years of age and older, and access to a library of bromodomain and extra-terminal (BET) domain inhibitors in both topical and oral forms for the potential treatment of major immuno-inflammatory conditions and rare skin diseases.

VYNE Intrinsic Value
0.0413 USD
Overvaluation 93%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-6 421%
=
Net Income
-33.6m
/
Revenue
524k
What is the Net Margin of Vyne Therapeutics Inc?

Based on Vyne Therapeutics Inc's most recent financial statements, the company has Net Margin of -6 421%.

Back to Top